Generic Precedex injection is indicated for the sedation of initially intubated and mechanically ventilated patients receiving treatment in an intensive care setting.
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the United States, subject to regulatory approval, no later than Feb. 21, 2025.
Mexiletine hydrochloride capsules are used to treat documented ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgment of a physician, is life-threatening.